Literature DB >> 15589942

Percutaneous bone marrow grafting for the treatment of tibial non-union.

Ashok Goel1, S S Sangwan, R C Siwach, Ahmad M Ali.   

Abstract

This is a prospective study to evaluate the efficacy of percutanous bone marrow grafting in patients with established tibial non-union and minimal deformity, whilst on the waiting list for open surgical procedures. Twenty consecutive patients with established tibial non-union and minimal deformity were treated by percutanous bone marrow injection under local anaesthesia. Bone marrow was obtained from the iliac crest, 3-5 ml of marrow was aspirated and injected immediately into and about the non-union site. Subsequent aspirations were performed 1 cm posterior to the previous site until a maximum of 15 ml of marrow was injected. Our results revealed clinical and radiological bone union following percutanous injection in 15 out of 20 patients (75%), with an average time to union following the first injection of 14 weeks. Four patients (20%) showed no evidence of union and were considered a failure. There were no cases of infection following the injection, and no complications at the donor site. We conclude that percutanous bone marrow grafting is a safe, simple, and reliable method of treating tibial non-union with minimal deformity. It is a limited invasive technique with minimal complications. It can be performed under local anaesthesia, is cost effective and potentially can avoid major surgical reconstruction.

Entities:  

Mesh:

Year:  2005        PMID: 15589942     DOI: 10.1016/j.injury.2004.01.009

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  30 in total

Review 1.  The possible use of stem cells in regenerative medicine: dream or reality?

Authors:  Sabrina Ehnert; Matthias Glanemann; Andreas Schmitt; Stephan Vogt; Naama Shanny; Natascha C Nussler; Ulrich Stöckle; Andreas Nussler
Journal:  Langenbecks Arch Surg       Date:  2009-07-31       Impact factor: 3.445

Review 2.  The role of stem cells in fracture healing and nonunion.

Authors:  Hangama C Fayaz; Peter V Giannoudis; Mark S Vrahas; Raymond Malcolm Smith; Christopher Moran; Hans Christoph Pape; Christian Krettek; Jesse B Jupiter
Journal:  Int Orthop       Date:  2011-08-24       Impact factor: 3.075

Review 3.  Bone tissue engineering: recent advances and challenges.

Authors:  Ami R Amini; Cato T Laurencin; Syam P Nukavarapu
Journal:  Crit Rev Biomed Eng       Date:  2012

4.  Stem cells and biological approaches to treatment of wrist problems.

Authors:  Alphonsus K S Chong; Min He
Journal:  J Wrist Surg       Date:  2013-11

Review 5.  Treatment of critical-sized bone defects: clinical and tissue engineering perspectives.

Authors:  Erika Roddy; Malcolm R DeBaun; Adam Daoud-Gray; Yunzhi P Yang; Michael J Gardner
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-10-28

Review 6.  Human stromal (mesenchymal) stem cells: basic biology and current clinical use for tissue regeneration.

Authors:  Abdullah Aldahmash; Walid Zaher; May Al-Nbaheen; Moustapha Kassem
Journal:  Ann Saudi Med       Date:  2012 Jan-Feb       Impact factor: 1.526

Review 7.  Stem cell homing in musculoskeletal injury.

Authors:  Eliza L S Fong; Casey K Chan; Stuart B Goodman
Journal:  Biomaterials       Date:  2010-10-08       Impact factor: 12.479

8.  Osteogenic protein-1 for long bone nonunion: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-04-01

Review 9.  Efficacy of minimally invasive techniques for enhancement of fracture healing: evidence today.

Authors:  Ippokratis Pountos; Theodora Georgouli; George Kontakis; Peter V Giannoudis
Journal:  Int Orthop       Date:  2010-02       Impact factor: 3.075

Review 10.  Percutaneous grafting with bone marrow autologous concentrate for open tibia fractures: analysis of forty three cases and literature review.

Authors:  Louis-Romée Le Nail; Julien Stanovici; Joseph Fournier; Marie Splingard; Jorge Domenech; Philippe Rosset
Journal:  Int Orthop       Date:  2014-04-13       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.